Spinocerebellar ataxia 23: Clinical Trials

4 trials for Spinocerebellar ataxia 23, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow Spinocerebellar ataxia 23: new trials by email Literature Review of Spinocerebellar ataxia 23 trials Research Report on Spinocerebellar ataxia 23

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery
Dalargin, 0.9 % NaCl - Postoperative Complications, Multiple Organ Failure
Phase 3CompletedBotkin Hospital2002025-05-132026-09-23
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingSanford Health200002010-07-012025-05-29
rTMS as a Treatment of Visceral Pain Secondary to Malignancy
Real rTMS(20 Hz, 10 trains, inter train interval 30 sc with total pulses 2000, intensity 80% of motor threshold) daily for 10 consecutive days (5 days/week), Sham rTMS (same parameters but with coil elevated and angled away from the head) every day for 10 consecutive days (5 days/week). - Malignancy
Not applicableCompletedAssiut University342010-01-012014-03-20
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Dynorphin 1 - 13 - Opioid-Related Disorders, Substance Withdrawal Syndrome
Phase 2CompletedUniversity of Minnesota1994-08-012015-05-27

Narrower conditions

3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)  ·  Acrodysostosis (1)  ·  Addison Disease (1)  ·  Agnosia (1)  ·  Alagille Syndrome (1)  ·  Alstrom Syndrome (1)  ·  Amnesia, Transient Global (1)  ·  Aniridia (1)  ·  Aniridia and Absent Patella (1)  ·  Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1)  ·  Ataxia (1)  ·  Ataxia Neuropathy Spectrum (1)  ·  Ataxia Telangiectasia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Abnormalities, Multiple (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenal Insufficiency (1)  ·  Amino Acid Metabolism, Inborn Errors (1)  ·  Amino Acid Transport Disorders, Inborn (1)  ·  Amnesia (1)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)

Interventions

Saline Solution (1)  ·  Sodium Chloride (1)  ·  dynorphin (1-13) (1)  ·  enkephalin-Leu, Ala(2)-Arg(6)- (1)

Sponsors

Assiut University (1)  ·  Botkin Hospital (1)  ·  Sanford Health (1)  ·  University of Minnesota (1)

Countries

United States (2)  ·  Australia (1)  ·  Russia (1)

Top investigators

Paul Pentel, M.D. (1)

NIH funding

R01DA008067 (1)